Yuling Ye

Fuzhou, 350014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Leveraging data-driven risk-adapted surveillance strategies after disease progression in locally advanced rectal cancer.

Leveraging data-driven risk-adapted surveillance strategies after disease progression in locally advanced rectal cancer.

Journal: BMC cancer

Published: March 16, 2026

Data-driven prognostic factors analysis and personalized follow-up strategies for post-progression survival in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy.

Data-driven prognostic factors analysis and personalized follow-up strategies for post-progression survival in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy.

Journal: Annals of medicine

Published: January 02, 2026

A study on the temporal patterns, anatomical distribution, and influencing factors of radiation therapy-associated second primary cancers in gynecological malignancies.

A study on the temporal patterns, anatomical distribution, and influencing factors of radiation therapy-associated second primary cancers in gynecological malignancies.

Journal: Frontiers in oncology

Published: October 16, 2025

Heavy metal burden in the urine and cancer risk.

Heavy metal burden in the urine and cancer risk.

Journal: Frontiers in oncology

Published: December 14, 2024

The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.

The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: June 20, 2023

Influence of age as a continuous variable on survival outcomes and treatment options in patients with upper thoracic esophageal carcinoma.

Influence of age as a continuous variable on survival outcomes and treatment options in patients with upper thoracic esophageal carcinoma.

Journal: Journal of Cancer

Published: February 13, 2023

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma.

Development of a prognostic nomogram and risk stratification system for upper thoracic esophageal squamous cell carcinoma.

Journal: Frontiers in oncology

Published: October 01, 2022

Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.

Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.

Journal: BMC cancer

Published: April 26, 2021

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma.

Journal: Molecular therapy oncolytics

Published: January 17, 2021

C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.

C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.

Journal: DNA and cell biology

Published: April 14, 2020

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.

Journal: Frontiers in oncology

Published: February 05, 2020

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.

Journal: Aging

Published: November 21, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026